Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

Alternative players in US distribution gaining market share

The leading three animal health distributors in the US could be facing more of a challenge from smaller competitors as their market share dipped in the last year. 

Markets Equipment & Technology

Krka finishes 2017 on a positive note with improved sales

Slovenian pharmaceutical company Krka has seen its animal health sales remain stable over 2017 with 1% year-on-year growth. 

Financial Results Pharmaceuticals

Animal Pharm Podcast #10: Zoetis gives an insight into its external innovation strategy

In this latest podcast, Animal Pharm editor Joseph Harvey speaks to Scott Brown, vice president of external innovation at Zoetis. The podcast below covers the company's blueprint for external collaboration, particularly with human health businesses. 

Zoetis R&D

Purdue inaugurates animal sciences complex to foster innovation

Purdue University has formally opened its new $60 million animal sciences complex in the US. 

R&D Research

Zoetis outlines $54 million supply site expansion

Zoetis has confirmed its plans to expand its global manufacturing and supply facility in Charles City, Iowa. 

Zoetis Vaccines

Medical marijuana pet bill introduced in New York

A new bill has been introduced in the New York State of Assembly to enable veterinarians to prescribe medical marijuana for pets.

United States Pain

Collaborative relations between animal health and human biotech continue to thaw in Boston snow

Earlier this month, animal health companies and human biotechnology specialists converged on a blizzard-hit Boston to seek potential cross-industry partnerships. Animal Pharm editor Joseph Harvey attended to sample the climate for collaboration between the two sectors.

North America United States

AHI study details animal health's prominent contribution to the US economy

The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).

United States Antiparasitics

ADUFA hearing explores expanded conditional approval of animal drugs

US lawmakers have urged the US FDA to expand its conditional approval process for animal drugs to help bring more critical veterinary medicines to market.

United States Policy & Regulation

Animal Pharm Podcast #9: Mark Heffernan explains Stonehaven Incubate's game plan

Stonehaven Incubate has been launched to translate innovation in the human health space into new animal health companies. Animal Pharm Joseph Harvey editor spoke to the firm's chief executive Mark Heffernan about this new home for start-ups. 

R&D Pharmaceuticals

Poïesis populates pipeline with investment the missing link

US companion animal medicines firm Poïesis Therapeutics is now working on a pipeline of eight candidates in-licensed from human biotechnology companies. 

R&D Companion Animals

FDA calls for comment on name guidance for veterinary medicines

The US FDA has issued draft guidance on proprietary names for new animal drugs.

North America United States
See All